Pubblicazioni

Lista delle pubblicazioni con responsabilità scientifica (§ = co-last; * = co-first)

 

Bercini Z, Cavallieri F, Campanini I, Cavazzuti L, Scaltriti S, Damiano B, Gessani A, Rossi J, Montepietra S, Valzania F, Merlo A. Instrumental Evaluation of the Effect of Oral Medium-Chain Triglycerides Oil on Paroxysmal Exercise‐Induced Dyskinesia in GLUT1 Deficiency Syndrome. Neurological Sciences, in press.

Di Rauso G, Ghibellini A, Grisanti S, Fioravanti V, Monfrini E, Toschi G, Portaro G, Argenziano G, Bacchin R, Rossi J, Sabadini R, Ferrari V, Melpignano A, Pacillo F, Scarano M, Groppi A, Gherardini L, Lucchi C, Biagini G, Montepietra S, Malaguti MC, Campanini I, Merlo A, Castellucci A, Ghidini A, Fraternali A, Versari A, Scaglioni A, Paul JJ, Bononi L, Gabbrielli M, Di Fonzo, A, Bauer P, Cavallieri F, Valzania F. Artificial Intelligence Predicts GBA1 Mutated Status in Parkinson's Disease Patients. Mov Disord Clin Pract. 2025 Sep 8. doi: 10.1002/mdc3.70334. 

Fant A, Trova S, Monfrini E, Treves G, Musacchia F, Landuzzi F, Mandich P, Amoroso A, Sanges R, Pandolfini L, Cavallieri F, Valzania F, Fioravanti V, Di Rauso G, Brescia G, Valente EM, Tiranti V, Romito LM, Reale C, Garavaglia B, Elia AE, Cavalli A, Di Fonzo A, Vecchi M, Gustincich S. Compound Heterozygous Structural Variants in Cases with Unsolved PRKN-Associated Parkinson's Disease. Mov Disord. 2025 Aug 30. doi: 10.1002/mds.70027. 

Cavallieri F, Bove F, Zampogna A, Castrioto A, Meoni S, Gessani A, Schmitt E, Pélissier P, Valzania F, Suppa A, Pinto S, Chabardès S, Fraix V, Moro E. Clinical predictors of speech changes after subthalamic neurostimulation in Parkinson's disease. Neurol Sci. 2025 Aug 25. doi: 10.1007/s10072-025-08420-3.

Kleinz T, Cavallieri F, Borsche M, Toschi G, Valzania F, Fioravanti V, Valente EM, Mitrotti P, Avenali M, Zittel S, Born R, Matarazzo M, Di Fonzo A, Monfrini E, Radefeldt M, Santinelli L, Griebner N, Shambetova C, Brand M, Gabbert C, Blauwendraat C, Trinh J, Beetz C, Bauer P, Brüggemann N; Global Parkinson’s Genetics Program (GP2); Klein C. RAB32 -linked Parkinson's disease: Deep phenotyping, MDSGene literature review, and application of SynNeurGe criteria. medRxiv [Preprint]. 2025 Jun 3:2025.06.03.25328628. doi: 10.1101/2025.06.03.25328628. 

Cavallieri F, Cavazzuti L, Damiano B, Portaro G, Scaltriti S, Montepietra S, Fioravanti V, Di Rauso G, Merlo A, Campanini I, Valzania F. Surface Dynamic Gait EMG Assessment of Paroxysmal Muscle Spasm in Stiff-Person Syndrome. Mov Disord Clin Pract. 2025 Jun 11. doi: 10.1002/mdc3.70156. 

Fontanesi D, Di Rauso G, Cavallieri F, Fioravanti V, Monfrini E, Rossi J, Toschi G, Sabadini R, Montepietra S, Merlo A, Campanini I, Cavazzuti L, Di Fonzo, A, Valzania F. Dopa responsive dystonia due to a GCH1 gene variant mimicking hereditary spastic paraparesis. Neurol Sci. 2025 Aug;46(8):4007-4009. doi: 10.1007/s10072-025-08079-w. 

Cavallieri F, Fraternali A, Arnone A, Fioravanti V, Monfrini E, Di Biasio F, Toschi G, Di Rauso G, Portaro G, Grisanti S, Salomone G, Kleinz T, Mandich P, Paul JJ, Beetz C, Bauer P, Ko JH, Bauckneht M, Melpignano A, Filice A, Di Fonzo, A, Klein C, Strafella AP, Valzania F. 18F-FDG PET findings in Parkinson's disease associated to RAB32 S71R variant. Parkinsonism Relat Disord. 2025 May;134:107343. doi: 10.1016/j.parkreldis.2025.107343. 

Bisquoli M, Cavallieri F, Di Rauso G, Monfrini E, Fioravanti V, Salomone G, Russo M, Rizzi R, Di Fonzo A, Valzania F. A De Novo SCN2A Variant in a Patient with Adult-Onset Dystonia Parkinsonism and Nigrostriatal Denervation. Mov Disord Clin Pract. 2025 Jun;12(6):867-869. doi: 10.1002/mdc3.70014. 

Fontanesi D, Cavallieri F, Groppi A, Gessani A, Di Rauso G, Montepietra S,Fioravanti V, Valzania F. Citalopram-Induced Tongue Dyskinesia. Can J Neurol Sci. 2025 Feb 19:1-3. doi: 10.1017/cjn.2025.28. 

Merlo A, Cavazzuti L, Bò MC, Cavallieri F, Bassi MC, Damiano B, Scaltriti S, Fioravanti V, Di Rauso G, Portaro G, Valzania F, Lusuardi M, Campanini I.Instrumental balance assessment in Parkinson's disease and parkinsonism. A systematic review with critical appraisal of clinical applications and quality of reporting. Front Neurol. 2025 Jan 29;16:1528191. doi:10.3389/fneur.2025.1528191.

Cavallieri F, Fraternali A, Arnone A, Campanini I, Marti A, Gessani A, Fioravanti V, Molinari MA, Di Rauso G, Antonelli F, Rispoli V, Feletti A, Stanzani R, Damiano B, Scaltriti S, Cavazzuti L, Bardi E, Corni MG, Cavalleri F, Biagini G, Pavesi G, Lusuardi M, Budriesi C, Merlo A, Versari A, Valzania F. Cerebral Amyloid-β Deposition, Axial Features, and Cognitive Alterations in Patients with Parkinson's Disease Treated with Bilateral STN-DBS: A Long-Term Cohort Study. J Pers Med. 2024 Dec 10;14(12):1150. doi: 10.3390/jpm14121150.

Radefeldt M, Lemke S, Chaichoompu K, Paul JJ, Curado F, Valzania F, Cavallieri F, Fioravanti V, Valente EM, Avenali M, Negrotti A, Hanagasi HA, Thonke S, Matarazzo M, Panzavolta A, Cerami C, Westenberger A, Klein C, Bauer P, Beetz C. Genetic and Epidemiological Insights into RAB32-Linked Parkinson's Disease. Mov Disord. 2025 Jan;40(1):147-151. doi: 10.1002/mds.30041. 

Galota F, Di Rauso G, Sireci F, Castellucci A, Cavallieri F, Monfrini E, Fioravanti V, Campanini I, Merlo A, Napoli M, Cavazzuti L, Grisanti S, Ferrari, S, Di Fonzo A, Valzania F. Obsessive-compulsive disorder as a first manifestation of Ataxia with Oculomotor Apraxia type 2 due to a novel mutation of SETX gene. Neurol Sci. 2025 Jan;46(1):469-472. doi: 10.1007/s10072-024-07761-9. 

Cavallieri F, Zedde M, Fioravanti V, Grisanti S, Napoli M, Moratti C, Pascarella R, Moro E, Valzania F. Pathophysiology of COVID-19-Related Extrapyramidal Disorders. Adv Exp Med Biol. 2024;1457:111-123. doi: 10.1007/978-3-031-61939-7_6. 

Cavallieri F, Di Rauso G, Fioravanti V, Senesi C, Esposito M, Valzania F. Just smile or not? A case of isolated smiling tremor. Neurol Sci. 2025 Feb;46(2):1051-1053. doi: 10.1007/s10072-024-07755-7. 

Cavallieri F, Lucchi C, Grisanti S, Monfrini E, Fioravanti V, Toschi G, Di Rauso G, Rossi J, Di Fonzo A, Biagini G, Valzania F. Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson's Disease: A Possible Factor Influencing Clinical Phenotype? Biomolecules. 2024 Aug 17;14(8):1022. doi:10.3390/biom14081022.

Westenberger A, Skrahina V, Usnich T, Beetz C, Vollstedt EJ, Laabs BH, Paul JJ, Curado F, Skobalj S, Gaber H, Olmedillas M, Bogdanovic X, Ameziane N, Schell N, Aasly JO, Afshari M, Agarwal P, Aldred J, Alonso-Frech F, Anderson R, Araújo R, Arkadir D, Avenali M, Balal M, Benizri S, Bette S, Bhatia P, Bonello M, Braga-Neto P, Brauneis S, Cardoso FEC, Cavallieri F, Classen J, Cohen L, Coletta D, Crosiers D, Cullufi P, Dashtipour K, Demirkiran M, de Carvalho Aguiar P, De  Rosa A, Djaldetti R, Dogu O, Dos Santos Ghilardi MG, Eggers C, Elibol B, Ellenbogen A, Ertan S, Fabiani G, Falkenburger BH, Farrow S, Fay-Karmon T, Ferencz GJ, Fonoff ET, Fragoso YD, Genç G, Gorospe A, Grandas F, Gruber D, Gudesblatt M, Gurevich T, Hagenah J, Hanagasi HA, Hassin-Baer S, Hauser RA, Hernández-Vara J, Herting B, Hinson VK, Hogg E, Hu MT, Hummelgen E, Hussey K, Infante J, Isaacson SH, Jauma S, Koleva-Alazeh N, Kuhlenbäumer G, Kühn A, Litvan I, López-Manzanares L, Luxmore M, Manandhar S, Marcaud V, Markopoulou K, Marras C, McKenzie M, Matarazzo M, Merello M, Mollenhauer B, Morgan JC, Mullin S, Musacchio T, Myers B, Negrotti A, Nieves A, Nitsan Z, Oskooilar N, Öztop-Çakmak Ö, Pal G, Pavese N, Percesepe A, Piccoli T, Pinto de Souza C, Prell T, Pulera M, Raw J, Reetz K, Reiner J, Rosenberg D, Ruiz-Lopez M, Ruiz Martinez J, Sammler E, Santos-Lobato BL, Saunders-Pullman R, Schlesinger I, Schofield CM, Schumacher- Schuh AF, Scott B, Sesar Á, Shafer SJ, Sheridan R, Silverdale M, Sophia R, Spitz M, Stathis P, Stocchi F, Tagliati M, Tai YF, Terwecoren A, Thonke S, Tönges L, Toschi G, Tumas V, Urban PP, Vacca L, Vandenberghe W, Valente EM, Valzania F, Vela-Desojo L, Weill C, Weise D, Wojcieszek J, Wolz M, Yahalom G, Yalcin- Cakmakli G, Zittel S, Zlotnik Y, Kandaswamy KK, Balck A, Hanssen H, Borsche M, Lange LM, Csoti I, Lohmann K, Kasten M, Brüggemann N, Rolfs A, Klein C, Bauer P. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study. Brain. 2024 Aug 1;147(8):2652-2667. doi: 10.1093/brain/awae188. 10.1007/s00266-024-04071-5. PMID: 38869520; PMCID: PMC11300619.

Di Rauso G, Cavallieri F, Monfrini E, Fraternali A, Fioravanti V, Grisanti S, Gessani A, Campanini I, Merlo A, Toschi G, Napoli M, Pascarella R, Silipigni,R, Finelli P, Paul JJ, Bauer P, Versari A, Di Fonzo A, Valzania F. A Case of 18p Chromosomal Deletion Encompassing GNAL in a Patient With Dystonia-Parkinsonism.
J Mov Disord. 2024 Apr;17(2):236-238. doi: 10.14802/jmd.23222. 

De Ieso S, Di Rauso G, Cavallieri F, Beltrami D, Marti A, Napoli M, Pascarella R, Feletti A, Fioravanti V, Toschi G, Rispoli V, Antonelli F, Puzzolante A, Pavesi G, Gasparini F, Valzania F. Longitudinal Neuropsychological Assessment of Symptomatic Edema after Subthalamic Nucleus Deep Brain Stimulation Surgery: A Case Series Study. Neurol Int. 2023 Dec 28;16(1):62-73. doi:
10.3390/neurolint16010004. 

Cavallieri F, Mulroy E, Moro E. The history of deep brain stimulation. Parkinsonism Relat Disord. 2024 Apr;121:105980. doi: 10.1016/j.parkreldis.2023.105980. 

Argenziano G, Cavallieri F, Castellucci A, Fioravanti V, Di Rauso G, Gessani A, Campanini I, Merlo A, Napoli M, Grisanti S, Rossi J, Toschi G, Zini C, Ghidini A, Valzania F. Vestibular Hypofunction in ARSACS Syndrome: A Possible Pitfall in the Differential Diagnosis of Recessive Cerebellar and Afferent Ataxias. Neurol Clin Pract. 2024 Feb;14(1):e200239. doi:
10.1212/CPJ.0000000000200239. 

Cavallieri F, Ghirotto L, Sireci F, Parmeggiani M, Pedroni C, Mardones FA, Bassi MC, Fioravanti V, Fraix V, Moro E, Valzania F. Caregivers' burden and deep brain stimulation for Parkinson disease: A systematic review of qualitative studies. Eur J Neurol. 2024 Mar;31(3):e16149. doi: 10.1111/ene.16149. 

Di Rauso G, Castellucci A, Cavallieri F, Tozzi A, Fioravanti V, Monfrini E, Gessani A, Rossi J, Campanini I, Merlo A, Ronchi D, Napoli M, Pascarella R, Grisanti S, Ferrulli G, Sabadini R, Di Fonzo A, Ghidini A, Valzania F. Speech, Gait, and Vestibular Function in Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome. Brain Sci. 2023 Oct 17;13(10):1467. doi:
10.3390/brainsci13101467.

Gessani A*, Cavallieri F*, Fioravanti V, Campanini I, Merlo A, Di Rauso G, Damiano B, Scaltriti S, Bardi E, Corni MG, Antonelli F, Cavalleri F, Molinari MA, Contardi S, Menozzi E, Fraternali A, Versari A, Biagini G, Fraix V, Pinto S, Moro E, Budriesi C, Valzania F. Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's disease. Sci Rep. 2023 Jul 15;13(1):11462. doi: 10.1038/s41598-023-38555-2. 

Cavallieri F, Di Rauso G, Gessani A, Budriesi C, Fioravanti V, Contardi S, Menozzi E, Pinto S, Moro E, Antonelli F, Valzania F. A study on the correlations between acoustic speech variables and bradykinesia in advanced Parkinson's disease. Front Neurol. 2023 Jul 18;14:1213772. doi: 10.3389/fneur.2023.1213772.

Biagioli N, Cavallieri F, Marti A, Di Rauso G, Fioravanti V, Monfrini E, Gasparini F, Beltrami D, Grisanti S, Rossi J, Toschi G, Fraternali A, Versari A, Napoli M, Pascarella R, Di Fonzo A, Valzania F. Levodopa responsive asymmetric parkinsonism as clinical presentation of progranulin gene mutation. J Neurol Sci. 2023 Aug 15;451:120737. doi: 10.1016/j.jns.2023.120737. 

Grisanti S, Fraternali A, Cavallieri F, Fioravanti V, Casali M, Toschi G, Ferri L, Sabadini R, Zedde M, Salomone G, Napoli M, Pascarella R, Ferrari V, Scarano M, Biagini G, Scaglioni A, Moro E, Versari A, Valzania F. Quantitative dopamine transporter imaging assessment in Parkinson's disease patients carrying GBA gene mutations compared with idiopathic PD patients: A case-control study. Brain Behav. 2023 Jul;13(7):e3060. doi: 10.1002/brb3.3060. 

Cavallieri F, Campanini I, Gessani A, Budriesi C, Fioravanti V, Di Rauso G, Feletti A, Damiano B, Scaltriti S, Guagnano N, Bardi E, Corni MG, Rossi J, Antonelli F, Cavalleri F, Molinari MA, Contardi S, Menozzi E, Puzzolante A, Vannozzi G, Bergamini E, Pavesi G, Meoni S, Fraix V, Fraternali A, Versari A, Lusuardi M, Biagini G, Merlo A, Moro E, Valzania F. Long-term effects of bilateral subthalamic nucleus deep brain stimulation on gait disorders in Parkinson's disease: a clinical-instrumental study. J Neurol. 2023 Sep;270(9):4342-4353. doi: 10.1007/s00415-023-11780-5. 

Cavallieri F, Gessani A, Merlo A, Campanini I, Budriesi C, Fioravanti V, Di Rauso G, Feletti A, Damiano B, Scaltriti S, Guagnano N, Bardi E, Corni MG, Antonelli F, Cavalleri F, Molinari MA, Contardi S, Menozzi E, Puzzolante A, Vannozzi G, Bergamini E, Pavesi G, Fraix V, Meoni S, Fraternali A, Versari A, Lusuardi M, Biagini G, Pinto S, Moro E, Valzania F. Interplay between speech and gait variables in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: A long-term instrumental assessment. Eur J Neurol. 2023 Jul;30(7):1963-1972. doi: 10.1111/ene.15803. 

Cavallieri F, Cury RG, Guimarães T, Fioravanti V, Grisanti S, Rossi J, Monfrini E, Zedde M, Di Fonzo A, Valzania F, Moro E. Recent Advances in the Treatment of Genetic Forms of Parkinson's Disease: Hype or Hope? Cells. 2023 Feb 27;12(5):764. doi: 10.3390/cells12050764. 

Argenziano G, Cavallieri F, Monfrini E, Gessani A, Russo M, Rizzi R, Fioravanti V, Grisanti S, Toschi G, Napoli M, Pascarella R, Budriesi C, Di Fonzo A, Zucco R, Valzania F. Deconstructing speech alterations in episodic ataxia type 2: Perceptual-acoustic analysis in a case due to CACNA1A gene mutation. Parkinsonism Relat Disord. 2023 Mar;108:105311. doi: 10.1016/j.parkreldis.2023.105311. 

Di Rauso G, Cavallieri F, Campanini I, Gessani A, Fioravanti V, Feletti A, Damiano B, Scaltriti S, Bardi E, Corni MG, Antonelli F, Rispoli V, Cavalleri F, Molinari MA, Contardi S, Menozzi E, Puzzolante A, Rossi J, Meletti S, Biagini G, Pavesi G, Fraix V, Lusuardi M, Fraternali A, Versari A, Budriesi C, Moro E, Merlo A, Valzania F. Freezing of Gait in Parkinson's Disease Patients Treated with Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Long-Term Overview. Biomedicines. 2022 Sep 7;10(9):2214. doi: 10.3390/biomedicines10092214. 

Cavallieri F, Fioravanti V, Bove F, Del Prete E, Meoni S, Grisanti S, Zedde M, Pascarella R, Moro E, Valzania F. COVID-19 and Parkinsonism: A Critical Appraisal. Biomolecules. 2022 Jul 11;12(7):970. doi: 10.3390/biom12070970. 

Fioravanti V, Cavallieri F, Di Fonzo A, Toschi G, Grisanti S, Salomone G, Zappia M, Valzania F. Axial Improvement after Casirivimab/Imdevimab Treatment for COVID-19 in Parkinson's Disease. Can J Neurol Sci. 2023 Sep;50(5):777-778. doi: 10.1017/cjn.2022.269. 

Fioravanti V, Cavallieri F, Rossi J, Macaluso MC, Valzania F. Subcortical generalized myoclonus as a presenting symptom of quetiapine overdose. Neurol Sci. 2022 Oct;43(10):6135-6136. doi: 10.1007/s10072-022-06174-w. 

Grisanti S, Ferri L, Cavallieri F, Fioravanti V, Vincenzi C, Toschi G, Grisendi I, Sabadini R, Paul JJ, Bauer P, Zedde M, Valzania F. Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations. Mov Disord. 2022 May;37(5):1117-1118. doi: 10.1002/mds.28996. 

Cavallieri F, Fioravanti V, Toschi G, Grisanti S, Napoli M, Moratti C, Pascarella R, Versari A, Fraternali A, Casali M, Paul JJ, Moro E, Bauer P, Zedde M, Valzania F. COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration? J Neurol. 2022 Jan;269(1):59-61. doi: 10.1007/s00415-021-10694-4.

Assenza F, Genovese M, Cabboi MP, Salomone G, Cavallieri F, Valzania F. Peribuccal and pharyngeal myorhythmia as a presenting symptom of hypertrophic olivary degeneration. Parkinsonism Relat Disord. 2021 Apr;85:141-143. doi: 10.1016/j.parkreldis.2021.02.019. 

Cavallieri F, Fioravanti V, Valzania F. Opicapone and acute levodopa challenge test: the big issue. Acta Neurol Belg. 2021 Oct;121(5):1347-1349. doi: 10.1007/s13760-021-01597-2. 

Cavallieri F, Sireci F, Fioravanti V, Toschi G, Rispoli V, Antonelli F, Costantini M, Ghirotto L, Valzania F. Parkinson's disease patients' needs during the COVID-19 pandemic in a red zone: A framework analysis of open-ended survey questions. Eur J Neurol. 2021 Oct;28(10):3254-3262. doi: 10.1111/ene.14745. 

Cavallieri F, Zedde M, Assenza F, Valzania F. Steroid-Responsive Acute Left-Arm Chorea as a Presenting Symptom of Moyamoya Disease. Can J Neurol Sci. 2021 Mar;48(2):287-289. doi: 10.1017/cjn.2020.155.